Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1409]

Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complication after COVID-19 vaccination

Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complication after COVID...

Lipid nanoparticles carry gene-editing cancer drugs past tumour defenses

Lipid nanoparticles carry gene-editing cancer drugs past tumour defenses

Mechanical transmission enables EMT cancer cells to drive epithelial cancer cell migration to guide tumour spheroid disaggregation

Mechanical transmission enables EMT cancer cells to drive epithelial cancer cell migration to guide tumour...

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Artificial intelligence tool predicts response to immunotherapy in lung and gynaecologic cancer patients

Artificial intelligence tool predicts response to immunotherapy in lung and gynaecologic cancer patients

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide

ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide

ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein

ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein

ASCO 2022: Nimotuzumab significantly improves overall survival for K-Ras wild-type advanced pancreatic cancer

ASCO 2022: Nimotuzumab significantly improves overall survival for K-Ras wild-type advanced pancreatic cancer

Screening every five years safe for women who test negative for HPV, study confirms

Screening every five years safe for women who test negative for HPV, study confirms

More from ecancer